Studies have shown that IGF-I/coupled with IGFBP-3 affords more efficient protection from insulitis, β-cell destruction, and T1D than IGF-I and has a potential as a prophylactic therapy in the prevention of autoimmune T1D (31). Here, IGF1 is linked to type 1 diabetes mellitus.